DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 60 filers reported holding DERMA SCIENCES INC in Q4 2015. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $477,000 | -76.2% | 101,235 | -63.8% | 0.19% | -75.8% |
| Q2 2015 | $2,005,000 | -75.8% | 280,000 | -71.4% | 0.78% | -78.5% |
| Q1 2015 | $8,283,000 | -25.0% | 977,923 | -17.5% | 3.64% | -31.4% |
| Q4 2014 | $11,038,000 | +14.1% | 1,185,632 | +2.1% | 5.31% | +27.8% |
| Q3 2014 | $9,676,000 | -27.1% | 1,161,604 | +1.2% | 4.16% | -29.6% |
| Q2 2014 | $13,275,000 | +13.2% | 1,148,292 | +24.1% | 5.90% | -3.6% |
| Q1 2014 | $11,729,000 | – | 925,000 | – | 6.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
| DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
| Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
| Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
| Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
| ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
| Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
| HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
| Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |